Global Autotransfusion Device Market 2022-2028
Autotransfusion is a medical procedure in which the lost blood of a patient is collected and returned to the same patient. It should be considered in every trauma patient while in the emergency department. Autotransfusion can also be used in patients undergoing surgery or any patient with anticipated blood loss without contraindications. In 2021, the global autotransfusion device market stood at USD 1,147 million. Recording a CAGR of 2.1% from 2022 to 2028, the worth is projected to reach ~USD 1,327 million by 2028, according to a new report by Gen Consulting Company.
The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global autotransfusion device market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the autotransfusion device industry.
This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, application, end user, and region. The global market for autotransfusion device can be segmented by product: devices, accessories. Autotransfusion device market is further segmented by application: cardiac surgeries, orthopedic surgeries, organ transplantation, trauma procedures, others. Based on end user, the autotransfusion device market is segmented into: ambulatory surgery centers (ASCs), hospitals, specialty clinics. On the basis of region, the autotransfusion device market also can be divided into: Asia Pacific, Europe, North America, Rest of the World (RoW).
By product:
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook